Randomized trial of supplemental β-carotene to prevent second head and neck cancer

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1457-1463

  Mayne, Susan T ^a   Cartmel, Brenda ^a   Baum, Marianna ^b   Shor Posner, Gail ^b   Fallon, Barbara G ^c   Briskin, Kenneth ^d   Bean, Judy ^e   Zheng, Tongzhang ^a   Cooper, Dennis ^a   Friedman, Craig ^a   Goodwin, W Jarrard ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; BIOLOGICAL MARKER; PLACEBO;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RECURRENCE; CANCER STAGING; CARCINOGENICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LARYNX CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PHARYNX CANCER; PRECANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND CANCER; SPUTUM CYTODIAGNOSIS; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

ADULT; AGED; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BETA CAROTENE; CARCINOMA, SQUAMOUS CELL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PLACEBOS;

EID: 0035866408     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cancer of the head neck
2. Second primary respiratory tract malignancies in glottic carcinoma
3. Second cancer following cancers of the buccal cavity and pharynx in Connecticut
4. Cigarette smoking and cancer of the mouth, pharynx and larynx. A continuing study
5. Multiple head and neck malignancies
6. Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early-stage disease
7. Cancer prevention: Diet and chemopreventive agents. Retinoids, carotenoids, and micronutrients
8. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
9. Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study
10. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer
11. A population-based trial of β-carotene chemoprevention of head and neck cancer
12. Sample size determination in clinical trials with time-dependent rates of losses and noncompliance
13. Effect of supplemental β-carotene on plasma concentrations of carotenoids, retinol and α-tocopherol in humans
14. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers
15. Effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease
16. Lack of effect of long-term supplementation with β carotene on the incidence of malignant neoplasms and cardiovascular disease
17. Mortality associated with low plasma concentration of β carotene and the effect of oral supplementation
18. β-carotene, carotenoids and disease prevention in humans
19. β-carotene, vitamin A., and lung cancer chemoprevention: Results of an intermediate endpoint study
20. Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study
21. Retinoids and β-carotene in head & neck (H&N) cancer chemoprevention: Preliminary results of two randomized trials from the Italian Head & Neck Chemoprevention Study Group (IH&NCSG)
22. National Cancer Institute sponsored cooperative clinical trials
23. Risk factors for lung cancer and for intervention effects in CARET, the β-Carotene and Retinol Efficacy Trial
24. Interim analysis of randomized chemoprevention trial of HNSCC